1-Castelhano N, Araujo NM, Arenas M. Heterogeneous recombination among Hepatitis B virus genotypes. Infection, Genetics and Evolution. 2017 Oct 1;54:486-90.
2-Seyed Moayed Alavian, Farahnaz Fallahian, Kamran Bagheri Lankarani. The Changing Epidemiology of Viral Hepatitis B in Iran. J Gastrointestinal Liver Dis. 2007; Vol.16 No 4, 403-406.
3-Wang HB, Wang QY, Yuan Q, Shan XY, Fu GH. Alanine aminotransferase is more sensitive to the decrease in hepatitis B virus‐DNA load than other liver markers in chronic hepatitis B patients. Journal of clinical laboratory analysis. 2017 Jan 1.
4-Qazi MQ, Ishaq MI. Frequency of hepatitis B and C seropositivity in prisoners. Biomedica. 2017 Feb 27;22(1):55-8.
5-Isa MA, Bello HS, Shettima A, Allamin IA. Prevalence of serological marker for chronic hepatitis b virus among patients attending Sokoto specialist hospital, Sokoto, Nigeria. Journal of Microbiology and Biotechnology Research. 2017 Mar 31;3(3):122-5
6-Qian L, Wang W, Zhou Y, Ma J. Effects of reduced glutathione therapy on chronic hepatitis B. Central- European Journal of Immunology. 2017;42(1):97.
7-Lavanchy D.Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat. 2004; 11:97-107
8-Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18: s 20-22.
9-Geo.f.brooks, Karen C.karrol, Janet S Butel and et al .Midical Microbiology.2015: The twenty-seven edition of Jawetz.
10-Mangen MJ, Stibbe H, Urbanus A, Siedenburg EC, Waldhober Q, de Wit GA, van Steenbergen JE. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile. Vaccine. 2017 May 31;35(24):3215-21.
11-Sun W, Zhao S, Ma L, Hao A, Zhao B, Zhou L, Li F, Song M. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission. BMC gastroenterology. 2017 Apr 13;17(1):51.
12-Karvonen T, Auranen K, Kuusi M, Leino T. Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy. Vaccine. 2017 Jan 11;35(3):412-8.
13-Shah DK, Jain SS, Khot AA, Gharat AR, Rajadhyaksha GC, Rathi PM. Low prevalence of hepatitis B and C infections among the healthcare workers despite low vaccination coverage for hepatitis B in Mumbai. Indian Journal of Medical Sciences. 2017 Mar 28;69(1):8-12.
14-Hossain KZ, Ahmad N, Noor-e-Alam SM, Sarker MJ, Khondoker FA, Mahtab MA. Correlation Between HBeAg Status, HBV DNA, ALT, AST, GGT and Liver Histological Activity in Patients with Chronic Hepatitis B Virus Infection. Journal of Clinical and Experimental Hepatology. 2017 Jul 1;7: S24-5.
15-Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody I blood donors and high risk groups in Iran. Vox Sang 1979; 37: 182-186.
16-Mohammad Jaffari R, Saadati N, Vaziri Esfarjani SH, Soorani Yancheshmeh A. A survey of the frequency of HBsAg status in pregnant women attending health centres in Ahvaz, Payesh Health Monitor. J Iranian Inst Health Sci Res. 2004; 3 (3):237-44.
17-Farhat A, KHademi G, Mazlouman SJ. The prevalence of hepatitis b carrier state in khorassan province of Iran. Saudi Medn 2003; 24:549-551.
18-Ghanaat J,Sadeghian A, Ghazvini K, Nassiri MR. Prevalence and risk factors for hepatitis B virus infection among STD pationts in northeast region of Iran . Med Sei Monit 2003; 9:cr91-94.